Cannabis Insights

November 12, 2024

Unlocking Cannabis Relief: Insights from 50K User Sessions on Tetragram

One of the biggest barriers a new cannabis consumer must overcome is finding the right product and dose for them. While this hurdle is present for […]
October 29, 2024

Smokers vs. Non-smokers: Who pays more?

Non-smoked products like edibles and beverages are becoming increasingly attractive to consumers who want the benefits of cannabis without the odor. Once the only way to […]
October 15, 2024

Which Cannabis Consumer Archetype are You?

We all know that cannabis consumers use for various reasons and come in all shapes, sizes, ages and genders. Gone are the days of assuming that […]
October 1, 2024

All Cannabis Use is Not Medical: Motivations for consumption and consumer behavior

Having a medical cannabis card is not the best indicator of motivation for consumption. There are many consumers who live in adult use markets, do not […]
September 17, 2024

How can cannabis retailers enhance loyalty?

As a market matures, any market, several things happen. Products become more reliable and known, increasing brand loyalty. Dispensaries start offering these known brands because they […]
September 3, 2024

Who is dominating the edibles market?

As edibles continue to grow in popularity, favorites among consumers are emerging. When it comes to edibles, consumers are looking for a consistent dose, a reasonable […]
August 20, 2024

The Power of Knowing Your Cannabis Consumer

Who are the consumers in your market?  Effective marketing starts with knowing who your consumers are, what they want, and what they expect to pay to […]
August 6, 2024

Cannabis Consumers Back Psychedelics for Therapeutic Use

The conversation around legalizing psychedelics for therapeutic use is heating up! Half of the cannabis consumers in our survey support access to substances like LSD, psilocybin, […]
July 23, 2024

Cannabis, Psychedelics and Rock n’ Roll

In a surprising twist, half of cannabis consumers think psychedelics like LSD, psilocybin, MDMA, and ketamine should be legal for therapeutic use. But here’s the kicker: […]